ArticleFrontiers in immunology2026

Engineering a juxtamembrane-targeting CAR T-cell against mesothelin: a novel binder resilient to shed antigen for enhanced efficacy against ovarian and pancreatic cancer.

John Scholler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.